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Abstract
Background: Medically Unexplained Symptoms (MUS) are frequently encountered in general practice. However,
little is known whether MUS affects labor market participation. We investigated the prospective association
between MUS at baseline and risk of long-term sickness absence (LTSA), unemployment, and disability pensioning in
a 5-year-follow-up study.
Methods: In the Danish Work Environment Cohort Study 2005, 8187 randomly selected employees from the
Danish general population answered a questionnaire on work and health. Responses were linked with national
registers on prescribed medication and hospital treatment. Participants were classified with MUS if they: a) had
reported three or more symptoms during the last month, and b) did not have a chronic condition, neither in the
self-reported nor the register data. We assessed LTSA, unemployment, and disability pensioning by linking our
data with National registers of social transfer payments.
Results: Of the 8187 participants, 272 (3.3 %) were categorized with MUS. Compared to healthy participants,
participants with MUS had an increased risk of LTSA (Rate ratio (RR) = 1.76, 95 % CI = 1.28–2.42), and of unemployment
(RR = 1.48, 95 % CI = 1.02–2.15) during follow-up. MUS participants also showed an elevated RR with regard to risk of
disability pensioning, however this association was not statistically significant (RR = 2.06, 95 % CI = 0.77–5.52).
Conclusion: MUS seem to have a negative effect on labor market participation defined by LTSA and unemployment,
whereas it is more uncertain whether MUS affects risk of disability pensioning.
Background
Medically unexplained symptoms (MUS) name the
phenomena of patients reporting diffuse physical symp-
toms of uncertain etiology, which cannot be conclusively
attributed to any detectable physical disorders. Due to
missing consensus concerning definition [1, 2], MUS is
known also by other terms, such as somatization [3, 4],
functional somatic symptoms [5, 6], and subjective
health complaints [7].
MUS is one of the most common reasons for seeking
health care [8–10]. The most often reported symptoms
comprise headache, joint-, back- and abdominal pain
[8, 11, 12]. The symptoms may vary in duration and in
severity, ranging from mild symptoms to serious condi-
tions with great suffering and disablement [2, 13–16].
Patients with MUS often report a severe impact on quality
of life and have high health care utilization [10, 17, 18].
Further, patients with MUS often undergo unnecessarily
medical examinations and treatments [19], which are
costly in personal and economic terms [10, 17, 18, 20],
both at a societal [21, 22] and at an individual level
[17, 20, 23].
Case studies from medical practice suggest that MUS
is a cause of sickness absence and reduced work func-
tion [24–27]. However, to our knowledge, no epidemio-
logic study has yet analyzed whether and to what extent
MUS is a risk factor for long-term sickness absence
(LTSA) and low labor market participation. Studies that
have analyzed the association between number of symp-
toms and LTSA have for most part not taken into
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account whether the symptoms might be due to a med-
ical condition. Instead, information about MUS have ei-
ther been self-reported [28] or estimated by long-term
sickness absence periods [26]. A Dutch study, for ex-
ample, found that employees with a high symptom score
accounted for approximately 40 % of work days lost dur-
ing two-year follow-up [28]. A Danish study showed that
the number of subjective health complaints predicted
risk of sickness absence [29] when adjusting for self-
reported history of seven diseases.
In this study, we aim to examine the association of
MUS with LTSA, unemployment and disability pension-
ing in a representative sample of the Danish workforce.
Using participants with no chronic disease and low
symptom score as the reference group, we examine the
risk of these three outcomes for a) participants without
a diagnosed chronic disease but with a high symptom
score, who we regard as possible MUS cases, b) partici-
pants with a chronic disease and a low symptom score,
and c) participants with a chronic disease and a high
symptom score. Further, we examine whether there is an
interaction between presence/absence of chronic disease
and high/low symptom score on risk of sickness absence,
unemployment and disability pensioning.
Methods
Study design and population
This is a prospective cohort study that merges survey
data with register data. Participants were drawn from
the Danish Work Environment Cohort Study (DWECS)
from 2005. DWECS was established in 1990, and con-
sists of a random sample of Danish adult residents,
drawn from the Central Population Register [30]. In
2005, 12,432 (62.5 %) Danish residents responded to the
survey either by self-administered questionnaire pro-
vided on paper (n = 9271), on the internet (n = 448) or
by telephone interview (n = 2713). For the purpose of
analysis for this article, we excluded the 2713 partici-
pants who had responded on the telephone, because
earlier analyses in DWECS had shown systematical dif-
ferences in response patterns in the telephone interview
survey compared to the paper and internet survey [31].
We further excluded 1525 participants who were 60 years
or older, as we wanted to focus on participants of work-
ing age at baseline (18–59), before the possibility of early
retirement. Finally, we excluded 7 participants with
missing values on variables included in the analyses,
yielding a final study population of 8187.
Using the unique social security number of the partici-
pants, we linked the survey data to data from four national
registries: 1) The Danish Register-based Evaluation of
Marginalization, (DREAM) [32, 33], that includes all social
transfer payments made in Denmark since 1991; 2) The
National Patient Registry [33] (NPR) that includes ICD
codes for all somatic in-patient and out-patient hospital
treatment in Danish hospitals since 1977; 3) The Danish
Psychiatric Central Research Register [34] (PCRR) that in-
cludes ICD codes for all psychiatric in-patient and out-
patient hospital treatment in Danish hospitals since 1969;
and 4) The Danish National Prescription Registry [35]
(DNPR) that includes information on prescribed drugs
since 1995.
Definition of participants with MUS and the three
comparison groups
We categorized each participant according to high or
low health symptom score. Symptoms were measured
with the MUS-population-based scale (MUS-POP), an
instrument that we had developed for studying symp-
toms scores in the DWECS sample. A detailed descrip-
tion of the development of the MUS-POP scale has been
presented elsewhere (Loengaard, unpublished Ph.D. dis-
sertation, can be requested from the corresponding au-
thor). Briefly, we used 28 self-reported health symptoms
from the DWECS questionnaire and applied confirma-
tory factor analysis and Receiver Operating Characteris-
tic (ROC) analysis to develop a scale that identifies
respondents with health complaints not attributable to a
known well-defined medical diagnosis, i.e., cases of
MUS. We tested the True Positive Rate and the False
Positive Rate of the scale with both poor self-rated
health and doctor-diagnosed MUS. The analyses showed
that 13 of the 28 items reflected specific symptom clus-
ters rather than a global scale and we consequently
excluded these items, leaving 15 items left for the
MUS-POP scale with a good fit for a global scale.
The 15 items were 1) Heat flush; 2) Palpitation; 3)
Stomach pain; 4) Heartburn or reflux; 5) Bloated
stomach; 6) Heavy head; 7) Muscle tension; 8) Hand,
arm or elbow pain; 9) Dizziness; 10) Concentration
problems; 11) Tight chest; 12) Itching, dry and irritated
eyes; 13) Discomfort or nausea; 14) Throat irritation,
voice fatigue or throat tension; and 15) No appetite.
We found that a symptom score of 3 or higher on the
MUS-POP global scale predicated poor self-reported
health and doctor-diagnosed MUS (Loengaard, unpub-
lished Ph.D. dissertation).
We further categorized each participant with regard to
presence or absence of chronic disease. For this classifica-
tion we combined information from self-report, informa-
tion from NPR and PCRR registers on hospitalization with
ICD-diagnose indicative of chronic disease, (e.g., allergy,
asthma, coronary heart disease, cancer), and information
from the DNPR register on prescription medication spe-
cific to chronic disease (e.g., insulin, asthma medication).
Non-chronic diseases, for example influenza or pneumo-
nia, non-psychotic psychiatric disorders, and diseases con-
sidered as part of functional somatic syndromes, such as
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migraine or fibromyalgia, were not included as indicators
of chronic disease.
Based on the categorization with regard to low or high
symptom scores and presence or absence of chronic dis-
ease we assigned each participant to one of four groups
(Fig. 1): 1) low symptom score (<3 symptoms) and no
chronic disease (denoted as the ‘healthy group’); 2) high
symptom score (≥3 symptoms) and no chronic disease
(denoted as the ‘high-symptom-no-chronic group’) who
we regarded as possible MUS cases; 3) low symptom
score (<3 symptoms) and chronic disease (denoted as
the ‘low-symptom-chronic group’); and 4) high symptom
score (≥3 symptoms) and chronic disease (denoted as
the ‘high-symptom-chronic group’).
Measurement of labor market status, sickness absence,
unemployment and disability pensioning at baseline
In the DWECS survey, participants were first asked about
their general labor market position, e.g., whether they
were self-employed, manual workers, or non-manual
workers or whether they were unemployed, studying, sick-
listed or retired. Next, participants who were active in the
labor market were asked about the specific type of work
they were doing and the specific type of industry they
were working in. Based on this information, we catego-
rized participants into 12 groups, 8 groups of participants
who were active in the labor market and 4 groups that
were non-active (see Table 1 for details).
Sickness absence in DWECS was assessed by asking
the participants “How many working days with sickness
absence did you had during the last year?”. Responses
were categorized into “low sickness absence” (0 to 5 days,
i.e., no more than one working week during the last
year) and “high sickness absence” (≥6 days). We also
assessed LTSA in the DREAM register. DREAM includes
information on all sickness absence compensations paid
by Danish municipalities [32]. This compensation is paid
by the municipalities to the employers, or, if a person is
not employed, directly to the sick-listed person. For the
purpose of analysis, we regarded sickness absence benefits
of 8 weeks or more in the 12 months preceding the
DWECS survey as indicative of LTSA. This cut-off point
was chosen, because after 8 weeks of sickness absence the
Danish municipalities will evaluate the status of the sick-
listed person and will initiate return to work measures, if
possible [36].
Measurement of long-term sickness absence, unemployment
and disability pensioning during follow-up
To examine risk of sickness absence and diminished
labor market participation prospectively, we followed up
all participants for 5 years in the DREAM register. Dur-
ing the follow-up period, we retrived from DREAM in-
formation on LTSA, i.e., sickness absence of 8 weeks or
more, onset of unemployment of at 8 weeks or more,
and disability pensioning.
Measurement of covariates
As covariates, we assessed in DWECS sex, age, and edu-
cation that was categorized into “no vocational educa-
tion”, “short education”, “medium length education” and
“long education”.
Statistical analysis
We used chi2 tests to compare the sociodemographic
characteristics (sex, age, education and labor market
position) of the ‘healthy group’ with the ‘high-symptom-
no-chronic group’, the ‘low-symptom-chronic group’, and
the ‘high-symptom-chronic-group’ at baseline. Next, using
logistic regression analyses we calculated odds ratios (OR)
examining whether the ‘high-symptom-no-chronic group’
and the two chronic disease groups differed from the
‘healthy group’ with regard to being out of work at base-
line and with regard to history of sickness absence during
the 12 months preceding baseline. Analyses were per-
formed with and without adjustment for sex, age, and
education. Analyses for being out of work at baseline were
carried out for all participants, whereas analyses for self-
reported and register-based sickness absence were carried
out only for participants who were in work. We also ana-
lyzed whether there was an interaction effect of chronic
disease (yes/no) with symptom score (high/low) on being
out of work and on sickness absence.
Using Poisson regression we calculated rate ratios (RR)
comparing participants in the ‘high-symptom-no-chronic
group’ and the two chronic disease groups with par-
ticipants in the ‘healthy group’ regarding risk of
LTSA, unemployment and disability pensioning during
the 5-year follow-up period. Only participants who
were active at the labor market at baseline were in-
cluded in these analyses. In the analyses on sickness
absence, we excluded participants with registered sick-
ness absence of one month before or after baseline.
Fig. 1 Categorization of the four compared groups according to
symptom score and chronic disease
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In the analyses on unemployment, we excluded partici-
pants with registered unemployment one month before or
after baseline. We calculated the RR both for each of the
three endpoints, separately and for the three endpoints
combined. We also analyzed whether there was an inter-
action effect of chronic disease (yes/no) with symptom
score (high/low) on the three endpoints and the combin-
ation of the three endpoints.
In all analyses participants were followed-up until
event, old-age pension, emigration out of Denmark,
death or end of follow-up, whichever came first. In
the analyses on sickness absence and unemployment,

















% (n) % (n) % (n) % (n)
Sex
Women 49.8 (1379) 74.6 (203) 55.9 (2382) 69.4 (614)
Men 50.2 (1392) 25.4 (69) 44.1 (1877) 30.6 (271) p < 0.0001 p < 0.0001 p < 0.0001
Age
18–29 21.8 (605) 22.8 (62) 16.8 (715) 15.8 (140)
30–39 25.0 (693) 19.5 (53) 24.1 (1027) 18.9 (167)
40–49 28.0 (776) 27.6 (75) 27.8 (1185) 25.2 (223)




20.7 (553) 28.9 (75) 20.4 (836) 27.6 (235)
Short education 14.2 (378) 13.9 (36) 14.0 (574) 17.1 (146)
Medium length
education
52.4 (1398) 48.1 (125) 52.2 (2140) 47.8 (408)
Long education 12.7 (340) 9.2 (24) 13.5 (552) 7.5 (64) p = 0.0147 p = 0.8566 p < 0.0001
Labor market position
Self-employed 6.6 (181) 4.8 (13) 6.4 (271) 2.9 (26)
Non-manual,
high grade
13.9 (383) 6.6 (18) 13.5 (570) 6.3 (56)
Non-manual,
intermediate grade
15.4 (425) 15.1 (41) 17.1 (726) 11.2 (99)
Non-manual,
low grade
17.9 (494) 21.0 (57) 17.5 (129) 14.6 (129)
Manual, skilled 15.2 (418) 13.7 (37) 12.0 (509) 10.2 (90)
Manual, semi-/unskilled 12.1 (332) 15.5 (42) 9.6 (407) 10.3 (91)
Work on special terms 0.5 (14) 1.5 (4) 2.2 (94) 5.9 (52)
Vocational
training/student
10.9 (301) 10.3 (28) 9.0 (382) 7.8 (69)
Out of work,
on leave
3.3 (92) 3.0 (8) 3.4 (145) 2.9 (26)
Out of work,
sickness absence
0.3 (9) 1.9 (5) 1.5 (62) 4.3 (38)
Out of work,
unemployed
3.2 (87) 4.8 (13) 4.1 (173) 6.8 (60)
Out of work,
retired
0.5 (14) 1.9 (5) 3.7 (156) 16.7 (147) p < 0.0001 p < 0.0001 p < 0.0001
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participants were further censored on the day of
disability pensioning and women were censored for
maternity leave. All analyses were adjusted for sex,
age, and education at baseline. The analyses on risk
of sickness absence were further adjusted for sickness
absence of at least eight weeks during the 12 months
before baseline, and the analyses on risk of unemploy-
ment were further adjusted for unemployment of at
least eight weeks during the 12 months before base-
line. All analyses were conducted in SAS, version 9.3.
In addition to the main analyses, we conducted two
sensitivity analyses. In the first sensitivity analysis we ex-
cluded participants aged 55–59, because in this age
range sickness absence or unemployment may be used
by some workers as an ‘exit pathway’ bridging the time
until early retirement benefits become available. In the
second sensitivity analysis we re-defined chronic disease
by excluding three self-reported conditions (‘hay fever’,
‘skin disease’ and ‘allergy’) that we considered as less dis-
abling than the other diseases.
This study has been approved by the acquired Danish
Data Protection Agency, journal number: 2011-54-1148,
in order of creating a register of personal data. Accord-
ing to Danish legislation, this study did not need ap-
proval by an ethic committee, because it was neither a
clinical trial nor did it include biological material.
Results
Study sample characteristics
Of the 8187 participants, 2771 (33.8 %) were categorized
into the ‘healthy group’, 272 (3.3 %) into the ‘high-symp-
tom-no-chronic group’, 4259 (52.0 %) into the ‘low-
symptom-chronic group’, and 885 (10.8 %) into the
‘high-symptom-chronic group’.
Table 1 shows the sociodemographic characteristics of
the four groups at baseline. The ‘high-symptom-no-
chronic group’ differed in several characteristics from
the participants in the ‘healthy group’ and the ‘low-
symptom-chronic group’. Participants in the ‘high-symp-
tom-no-chronic group’ were more likely to be women
(74.6 vs. 49.8 and 55.9 %), and to have no vocational
education (28.9 vs. 20.7 and 20.4 %), and were less likely
to be non-manual workers of high occupational grade
(6.6 vs. 13.9 and 13.5 %). Further, retirement was more
likely in the ‘high-symptoms-no-chronic group’ than in
the ‘healthy group’ (1.9 vs. 0.5 %) but less likely than in
the ‘low-symptom-chronic group’ (3.7 %) and the ‘high-
symptom-chronic group’ (16.7 %).
Being out of work at baseline and sickness absence
before baseline
Table 2 shows analyses on being out of work at baseline
and on LTSA in the 12 months before baseline. Com-
pared to the ‘healthy group’, the ‘high-symptom-no-
chronic group’ showed a higher likelihood of being
out of work in the crude analysis, but no significant
difference in the adjusted analysis (OR = 1.35, 95 %
CI = 0.89–2.06). In contrast, the groups with chronic
disease – with and without high symptoms – had sig-
nificantly increased odds ratios of being out of work
at baseline. In separate analyses, we evaluated a pos-
sible interaction between reporting symptoms and
having a chronic disease with regards to being out of
work. We found a statistically significant interaction
(P = 0.0037), indicating that people with both a high
symptom level and a chronic disease had a higher
likelihood of being out of work than would have been
predicted from each of the two indicators alone.
Participants in the ‘high-symptom-no-chronic group’
were more likely to have self-reported sickness absence
of 6 days or more (OR = 2.16, 95 % CI = 1.61–2.92) in
the adjusted analyses than the ‘healthy group’. This
odds ratio was higher than the risk for the chronic dis-
ease group with a low symptom score (OR = 1.47, 95 %
CI = 1.29–1.67), but lower than the risk for the chronic
disease group with a high symptom score (OR = 3.28,
95 % CI = 2.70–3.99). In separate analyses, we found no
interaction between symptom level and chronic disease
on likelihood of sickness absence before baseline. Ana-
lyses, of register-based LTSA of 8 consecutive weeks or
more, showed similar results. The odds ratio was signifi-
cantly increased for the ‘high-symptom-no-chronic group’
(OR = 3.36, 95 % CI = 1.83–6.16), higher than the odds
ratio in the ‘low-symptom-chronic group’ and lower than
the odds ratio in the ‘high-symptoms-chronic group’.
Similarly, we found no indications of an interaction.
Risk of long-term sickness absence, unemployment and
disability pensioning during follow-up
Table 3 shows the prospective associations with risk of
LTSA, unemployment and disability pensioning among
those participants from the four groups who were actively
participating in the labor market at baseline. Compared to
the ‘healthy group’, participants in the ‘high-symptoms-no-
chronic group’ were at increased risk of LTSA in the
adjusted analyses (RR = 1.76, 95 % CI = 1.28–2.42). Similar
to results for the retrospective analyses, the risk in the
‘high-symptom-no-chronic group’ was higher than the
risk in the ‘low-symptom-chronic group’ and lower than
the risk in the ‘high-symptom-chronic group’.
The ‘high-symptoms-no-chronic group’ showed an in-
creased risk of unemployment in the adjusted analyses
(RR = 1.48, 95 % CI = 1.02–2.15). There was also a sig-
nificantly increased risk in the ‘high-symptoms-chronic
group’ but not in the ‘low-symptom-chronic group’.
Participants in the ‘high-symptom-no-chronic group’
showed an increased risk of disability pensioning in the
crude analysis (RR = 2.82, 95 % CI = 1.14–6.96). After
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adjustment for covariates the RR dropped to 2.06 and
statistical significance was lost. The risk of disability
pensioning was significantly increased for both the’low-
symptom-chronic group’ (RR = 3.59) and the ‘high-
symptom-chronic group’ (RR = 12.32).
In none of the prospective analyses did we find a sta-
tistically significant interaction between level of symp-
toms and chronic disease.
When we combined all three events, LTSA, un-
employment and disability pensioning, we found that
the participants in the ‘high-symptoms-no-chronic
group’ had a significantly increased risk of experiencing
at least one of the three events during follow-up com-
pared to the participants in the ‘healthy group’ (RR = 1.56,
95 % CI = 1.19–2.04). This risk was higher than the risk
for the ‘low-symptom-chronic group’ but lower than the
risk for the ‘high-symptom-chronic group’. We did not
find a significant interaction effect in the analysis.
Sensitivity analyses
We conducted two sensitivity analyses. First, we re-
peated the prospective analyses on risk of LTSA, un-
employment and disability pension (Table 3) while
excluding the 1294 participants who were 55 years or
older. Compared to the ‘healthy group’, the ‘high-symp-
tom-no-chronic group’ had a RR of 1.90 (95 % CI:
1.37–2.63) for LSTA and 1.58 (95 % CI: 1.08–2.32) for
unemployment in this sensitivity analysis, similar to the
results from the main analysis reported in Table 3. For
disability pensioning the RR increased more markedly
when excluding participants aged 55 years or older and
was statistically significant (RR = 3.06, 95 % CI: 1.08–8.62),
whereas it was not statistically significant in the main ana-
lysis (Table 3).
Second, we repeated the analyses from Table 3, while
no longer considering self-reported ‘hay fever’, ‘skin dis-
ease’ and ‘allergy’ as a chronic disease, because these
conditions presumably have a relatively low impact on
disability. Using this new chronic disease definition, the
RR for the ‘high-symptom-no chronic group’ was 2.11
(95 % CI: 1.60–2.68) for LTSA, 1.64 (95 % CI: 1.24–2.18)
for unemployment and 3.29 (95 % CI: 1.67–6.47) for dis-
ability pensioning. Thus, also in this second sensitivity
analysis, the most substantial change was observed for
disability pensioning. For the two chronic disease
groups, the RR for disability pensioning was 4. 27 (95 %
CI: 3.13–7.13, ‘low-symptom-chronic’) and 14.43 (95 %
CI: 9.42–22.34, ‘high-symptom-chronic’), respectively,
when using the re-defined chronic disease measure.
Discussion
Summary of results
In this study with a random sample of the Danish popu-
lation, we found that compared to healthy participants,
participants in the ‘high-symptom-no-chronic group’,
which we regarded as possible MUS cases, were more
often female, had lower education, were less likely to be
non-manual workers of high occupational grade and
Table 2 Comparison of labor market participation and sickness absence at baseline in the four groups
Number Cases % (N) Crude OR (95 % CI) Adjusted OR (95 % CI)
Out of work at baseline
Healthy group 2771 7.40 (205) 1 (Reference) 1 (Reference)
High-symptom-no-chronic group (MUS) 272 11.40 (31) 1.61 (1.08–2.40) 1.35 (0.89–2.06)
Low-symptom-chronic group 4259 12.63 (538) 1.81 (1.53–2.14) 1.71 (1.43–2.04)
High-symptom-chronic group 885 30.62 (271) 5.53 (4.52–6.76) 4.52 (3.65–5.60)
Six days or more of sickness absence, 12 months
before baseline (self-reported)
Healthy group 2566 17.42 (447) 1 (Reference) 1 (Reference)
High-symptom-no-chronic group (MUS) 241 31.54 (76) 2.18 (1.63–2.92) 2.16 (1.61–2.92)
Low-symptom-chronic group 3721 23.68 (881) 1.47 (1.30–1.67) 1.47 (1.29–1.67)
High-symptom-chronic group 614 29.83 (256) 3.39 (2.80–4.10) 3.28 (2.70–3.99)
Long-term sickness absence of 8 consecutive weeks,
12 months before baseline (register data)
Healthy group 2771 2.06 (57) 1 (Reference) 1 (Reference)
High-symptom-no-chronic group (MUS) 272 7.72 (21) 3.64 (2.00–6.62) 3.36 (1.83–6.16)
Low-symptom-chronic group 4259 5.56 (237) 2.37 (1.70–3.30) 2.29 (1.63–3.21)
High-symptom-chronic group 885 12.88 (114) 6.94 (4.72–10.19) 6.20 (4.18–9.19)
Out of work analyses: All participants (n = 8187); Sickness absence analyses: Only participants who were actively participating in the labor market at
baseline (n = 7142)
Adjusted OR are adjusted for sex, age, education
Odds ratios not including unity are printed in bold
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more likely to be retired. Participants in this group had
an increased risk of LTSA and unemployment during
the five-year follow-up. They also had an increased risk
of disability pensioning that was statistically significant
in the crude analysis of the main sample and in both the
crude and adjusted analyses of two sensitivity analyses,
although not in the adjusted analysis of the main
sample. For both LTSA and unemployment, the risk in
the ‘high-symptom-no-chronic group’ was higher than
among participants with a low symptom score and a
chronic disease, but lower than among participants
with a high symptom score and a chronic disease.
The baseline analyses showed that participants from
the two chronic disease groups and (in the crude ana-
lysis) also participants from the ‘high-symptom-no-
chronic group’ were more likely to be out of work than
the ‘healthy group’. It could have been assumed that par-
ticipants who, despite their chronic disease or their high
symptom score, were working at baseline, had somehow
found a way to reconcile their health condition with job
requirements and therefore would not be at increased
risk of labor market participation during follow-up. This
was not the case. The ‘high-symptom-non-chronic
group’ and the ‘high-symptom-chronic group’ were at
increased risk of unemployment and both chronic
groups were at increased risk of disability pensioning.
Thus, although our sample in the prospective analysis
consisted of employees who had managed to keep labor
market attachment at baseline despite their health
condition, they were still at increased risk of losing labor
market attachment during follow-up.
Comparison with previous findings
Previous studies have found that high symptoms scores
were associated with sickness absence [29, 37], and that
people with high symptom scores among sick-listed were
more disabled, had prolonged sick leaves and were more
often dismissed than people with a low symptom score
[26]. Additionally, a study in the Netherlands showed
that those people reporting most symptoms accounted
for most parts of the work days lost during a two-year
follow-up [28]. Although these studies were not exactly
Table 3 Risk of long-term sickness absence, unemployment and disability pensioning during 5-year follow-up in the four groups
Number Cases % (N) Crude RR (95 % CI) Adjusted RR (95 % CI)
Long-term sickness absence 8 weeks
Healthy group 2433 10.81 (263) 1 (Reference) 1 (Reference)
High-symptom-no-chronic group (MUS) 220 21.36 (47) 2.09 (1.53–2.85) 1.76 (1.28–2.42)
Low-symptom-chronic group 3433 15.38 (528) 1.46 (1.26–1.69) 1.38 (1.19–1.61)
High-symptom-chronic group 519 30.44 (158) 3.12 (2.56–3.08) 2.57 (2.09–3.15)
Unemployment 8 weeks
Healthy group 2431 10.32 (251) 1 (Reference) 1 (Reference)
High-symptom-no-chronic group (MUS) 224 14.73 (33) 1.47 (1.02–2.11) 1.48 (1.02–2.15)
Low-symptom-chronic group 3471 11.38 (395) 1.11 (0.94–1.30) 1.14 (0.97–1.34)
High-symptom-chronic group 560 20.89 (117) 2.12 (1.70–2.62) 2.05 (1.64–2.58)
Disability pensioning
Healthy group 2756 0.80 (22) 1 (Reference) 1 (Reference)
High-symptom-no-chronic group (MUS) 267 2.25 (6) 2.82 (1.14–6.96) 2.06 (0.77–5.52)
Low-symptom-chronic group 4097 3.05 (125) 3.86 (2.46–6.08) 3.59 (2.23–5.77)
High-symptom-chronic group 738 11.38 (84) 14.93 (9.34–23.88) 12.32 (7.51–20.21)
Any of the three events
Healthy Group 2367 18.50 (438) 1 (Reference) 1 (Reference)
High-symptom-no-chronic group (MUS) 211 30.81 (65) 1.78 (1.37–2.31) 1.56 (1.19–2.04)
Low-symptom-chronic group 3294 23.53 (775) 1.29 (1.15–1.46) 1.27 (1.13–1.43)
High-symptom-chronic group 488 43.85 (214) 2.65 (2.25–3.13) 2.43 (2.05–2.87)
All analyses restricted to participants with labor market participation at baseline (sample, n = 7858)
Long-term sickness absence: adjusted for sex, age, education, and history of long-term sickness absence. Participants on sickness absence at baseline or at one
month preceding or following baseline were excluded (sample, n = 6605)
Unemployment: adjusted for sex, age, education, and history of unemployment. Participants on unemployment at baseline or at one month preceding or
following baseline were excluded (sample, n = 6686)
Disability pensioning: adjusted for sex, age, education
Any of the three events: Adjusted for sex, age, education, history of long-term sickness absence, history of unemployment. Participants on sickness absence or
unemployment at baseline or at one month preceding or following baseline were excluded (sample, n = 6360)
Rate Ratios not including unity are printed in bold
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comparable with our study, their findings match our
findings about increased risk of LTSA.
It has been well agreed on that MUS can be disabling
[12, 13, 38], and that LTSA increases the risk of both un-
employment and disability pensioning [39, 40]. However,
to the best of our knowledge there have not been any
population-based studies examining the risk of unemploy-
ment and disability pensioning among people with MUS.
The findings from our study suggest that people with
MUS are at increased risk for unemployment and maybe
also for disability pensioning, although statistical signifi-
cance was lost in the adjusted analysis. Further, our results
showed that participants with a high symptom score and a
chronic disease had a 12-fold increased risk for disability
pensioning, which was substantially higher than in any
other of the examined groups.
Methodological consideration
This is a non-experimental, observational epidemio-
logical study and therefore causal inference has to be
drawn with caution as we cannot rule out that un-
measured factors may have confounded the association
of our predictor variables and the different endpoints.
This said, we believe that our study has several meth-
odological strengths that support a causal interpretation
of the findings. These strengths are in particular the use
of a representative sample of a national workforce, the
fairly large sample and the decent response rate of
62.5 %. The availability of Danish national registers
allowed us to assess prevalence of a diagnosed disease
not only by self-report but also by registered ICD-codes.
In the prospective analyses, the endpoints of LTSA,
unemployment and disability pensioning were assessed
by another national register, which allowed a complete
follow-up of all participants.
The main methodological challenge of this study is the
assessment of MUS. We had no clinical examinations
available in the study, and therefore our measurement of
MUS was based on combining a high symptom score
with the absence of a doctor-diagnosed chronic disease,
which we assessed both by self-report and register-data.
We reasoned that people who are suffering from a high
symptom score and at the same time do not have a
doctor-diagnosed chronic disease are likely to suffer
from symptoms that cannot be medically explained, i.e.,
from MUS. In an earlier analysis, this method was able
to predict doctor-diagnosed MUS (Loengaard, unpub-
lished Ph.D. thesis).
We acknowledge, though, that it is likely that this
assessment method has led to some misclassification.
Because we had only information available about chronic
disease before and until baseline, we cannot rule out that
for some participants the symptoms were medically
unexplained at baseline, but got a medical explanation at
some point during follow-up. Thus, while such partici-
pants were correctly classified at baseline, they might
not be correctly classified during the whole follow-up.
On the other hand, it is possible that some of the high
symptom scores in the chronic disease group were not
caused by the specific chronic disease of the participants
but had other causes, including causes that were not
medically explained – i.e., there might had been in some
cases a co-existing of both chronic disease and MUS.
Consequently, these participants should have been
regarded as the MUS participants.
In our study almost two thirds of the participants had
a chronic disease, which is a very high number taken
into account that these participants were mostly part of
the workforce. This high prevalence may be due to our
inclusive approach that combined both self-reported and
register-based doctor diagnosed diseases and which in-
cluded also diseases that had their onset many years ago.
Thus, a certain amount of the chronic diseases, in
particular those that we assessed via the registers, might
not had played a role in the daily life of the participants
when they filled in the survey.
Finally, while the initial response rate of 62.5 % is
decent for a large-scale epidemiological study, we de-
cided to exclude all participants who had responded to
the questions in a telephone interview instead of filling
in the paper questionnaire or responding to an internet
questionnaire. This reduced our sample size markedly
and has reduced statistical power in the analyses. We
would have preferred to include all participants, how-
ever, we decided against this because of previous evi-
dence from DWECS showing that response patterns to
several key questions deviated substantially depending
on whether data was collected by a telephone interview
or by paper questionnaire or internet survey [31].
Implication
It is well-accepted that MUS severely affects quality of
life [38, 41] and predicts impaired health status [42].
Our results show that MUS also puts employees at a
considerable risk of LTSA and unemployment. LTSA in
itself is known to have negative consequences [43] at a
societal level by increasing the cost of social benefit pay-
ment, for the workplace due to productivity loss, and for
the individual where LTSA increases the risk of adverse
economic and social conditions [44–46]. Studies have
shown that employees on LTSA often feel guilty for not
being able to work and for being a burden for society
[45]. This feeling of guilt may cause alienation and with-
drawal from social activities [45]. Some studies have sug-
gested that these feelings of guilt and alienation and the
withdrawal from social activities are even more en-
hanced in employees’ sick listed with MUS, as the lack
of a medical diagnosis and the need to’proof ’ [47] that
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the symptoms are’real’ may act as an additional psycho-
logical strain [47]. Such strain may result into passivity
and social isolation [24], which could initiate a process
of marginalization [39].
Our results are potentially important for health social
security professionals who are working with people
suffering from MUS. These professionals need to be
aware of that employees with MUS are at increased risk
of LTSA, unemployment and maybe also disability
pensioning, even though employees with MUS lack a
medical diagnosis. Health and social security profes-
sionals may consider informing employees with MUS
about this increased risk. Social security professionals
may further consider including employees with MUS
into prevention or re-integration programs aimed at
individuals at high risk for loss of labor market participation.
Conclusions
To conclude, our findings suggest that MUS not only af-
fects well-being, but have severe consequences in terms
of LTSA and unemployment. We recommend that these
possible consequences are taken into consideration by
health and social security professionals who are working
with people suffering from MUS.
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